Zorcell (IR-502) / Immune Response BioPharma - LARVOL DELTA

Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile. (PubMed) - Acta Ophthalmol - "This means that conjunctival melanoma patients may benefit from therapies that are effective for cutaneous and mucosal melanoma. Additionally, the identification of several up-regulated microRNAs may prove to be useful as prognostic or therapeutic targets in conjunctival melanoma."

Journal • Biosimilar • Melanoma • Ocular Melanoma • Oncology